Oncolytics Biotech is trading 10.1% up at $1.02 today, driven by speculative interest and trading momentum despite a lack of fresh company-specific news or fundamental catalysts.
- The move extends a volatile stretch for the stock, which has experienced sharp price swings in both directions over the past week.
- Market analysts note the gains appear driven by technical trading flow rather than fundamentals, particularly as the broader biotechnology sector is currently trading lower.